ArticleActa bio-medica : Atenei Parmensis2022
The scenario of the studies on ragweed (Ambrosia Sp.) and related issues from its beginning to today: a useful tool for future goals in a one health approach.
Article in Acta bio-medica : Atenei Parmensis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 1 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 4 institutions in 4 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
aimAirborne ragweed pollen is one of the agents of respiratory allergies in our changing environment. The monitoring of pollen is essential to manage pollen allergy and to improve its forecasting methods. Moreover, the control and fight against ragweed plants is important. Aim of this study is to understand the scenario of the studies on ragweed over time.
methodsWe searched PubMed and Scopus for articles published until July 2022 reporting the words "ragweed". Articles written in all languages were included.
resultsScopus was the database with the highest number of published papers. Among the papers on ragweed, the papers citing the word "allergy" were 59.4% in PubMed and 37,6% in Scopus. The subject areas more addressed were medicine, immunology, genetics/molecular biology, but agricultural/biological sciences too and, interestingly, other subjects like social sciences, art, humanistic, etc.). Among the top 40 institutions supporting research, 8 were European, 4 Asian, 1 Russian and 21 were American, the other 6 were pharmaceutical companies.
conclusionsThis study shows a picture of the ragweed studies and some related subjects over time. A gap between the number of biomedical and not biomedical issues was evident. There is a need for greater involvement of institutions into support of knowledge and fight ragweed. The results will provide a useful tool to identify future goals in a global approach of ragweed related issues.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.